Replies to post #3064 on CytoSorbents Corporation (CTSO)

[dr_lowenstein]

We have all seen the presentation, however, there is no information that I have seen that documents the ex-factory revenues for Toray, or Spectral. If they actually can get $10,000 per patient in revenue for this device, I would be amazed. Also, we all have seen the company propaganda about possible prices, but until the product is actually sold, I would take a wait and see attitude.

[dr_lowenstein]

This however, has nothing to do with Fresenius. It is being suggested by some that Fresenius will purchase CTSO. Of course, that is possible, but I question how likely that is given their purchase of Renal Solutions.